David A. Siegel Nuvasive Inc Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.71 - $44.15 $11.8 Million - $14.2 Million	-321,700 Reduced 32.2%	677,400 $28.2 Million
Q1 2023 May 15, 2023	BUY	$36.81 - $48.12 $24.4 Million - $31.9 Million	663,900 Added 198.06%	999,100 $41.3 Million
Q4 2022 Feb 14, 2023	BUY	$35.68 - $44.71 $8.33 Million - $10.4 Million	233,400 Added 229.27%	335,200 $13.8 Million
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $3.22 Million - $4.09 Million	75,800 Added 291.54%	101,800 $4.46 Million
Q1 2022 May 16, 2022	BUY	$48.09 - $57.79 $423,192 - $508,552	8,800 Added 51.16%	26,000 $1.47 Million

Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $2.45 Million - $3.25 Million	-51,900 Reduced 75.11%	17,200 $903,000
Q3 2021 Nov 15, 2021	SELL	$56.91 - $67.81 $18 Million - $21.5 Million	-316,800 Reduced 82.09%	69,100 $4.14 Million
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $6.95 Million - $7.79 Million	108,600 Added 39.16%	385,900 $26.2 Million
Q1 2021 May 17, 2021	SELL	$53.26 - $68.08 $7.91 Million - $10.1 Million	-148,500 Reduced 34.88%	277,300 $18.2 Million
Q4 2020 Feb 16, 2021	BUY	$43.41 - $56.51 $18 Million - $23.5 Million	415,600 Added 4074.51%	425,800 $24 Million
Q3 2020 Nov 16, 2020	SELL	$47.43 - $60.75 $417,384 - $534,600	-8,800 Reduced 46.32%	10,200 $495,000
Q2 2020 Aug 14, 2020	SELL	$43.51 - $66.59 $143,583 - $219,747	-3,300 Reduced 14.8%	19,000 $1.06 Million
Q1 2020 May 15, 2020	BUY	$32.82 - $81.13 $234,006 - $578,456	7,130 Added 47.0%	22,300 $1.13 Million
Q4 2019 Feb 14, 2020	BUY	$60.96 - $77.7 $560,832 - $714,840	9,200 Added 154.1%	15,170 $1.17 Million
Q3 2019 Nov 14, 2019	SELL	$55.78 - $68.08 $167,340 - $204,240	-3,000 Reduced 33.44%	5,970 $378,000
Q2 2019 Aug 14, 2019	SELL	$53.69 - $65.47 $2.31 Million - $2.82 Million	-43,100 Reduced 82.77%	8,970 $525,000
Q1 2019 May 15, 2019	BUY	$44.53 - $58.9 $1.9 Million - $2.52 Million	42,700 Added 455.71%	52,070 $2.96 Million
Q4 2018 Feb 14, 2019	BUY	$47.64 - $71.26 $446,386 - $667,706	9,370 New	9,370 $464,000
Q2 2018 Aug 14, 2018	SELL	$48.15 - $56.68 $369,310 - $434,735	-7,670 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $1.97 Million - $2.62 Million	-42,800 Reduced 84.8%	7,670 $400,000
Q4 2017 Feb 14, 2018	BUY	$50.58 - $60.79 $1.82 Million - $2.19 Million	36,000 Added 248.79%	50,470 $2.95 Million
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $774,723 - $983,960	14,470	14,470 $803,000

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account